EuroFlow develops and standardizes fast, accurate, and highly sensitive flow cytometric tests for diagnosis and prognostic (sub)classification of hematological malignancies as well as for evaluation of treatment effectiveness during follow-up. In addition to innovation, EuroFlow offers a number of services to improve the quality of diagnostics in the field of hemato-oncology worldwide, including Educational workshops, development of educational materials, organization of QA rounds and distribution of standardized protocols.
The EuroFlow Consortium consists of 19 diagnostic research groups, which are regarded as experts in the fields of flow cytometric and molecular diagnostics. Together these groups have sufficient complementarity and congruence to cover all aspects of innovation, standardization, and validation of highly sensitive flow cytometric tests for diagnosis and follow-up.
The main objective of EuroFlow is the development and standardization of fast, accurate, and highly sensitive flow cytometric tests for diagnosis and prognostic (sub)classification of hematological malignancies as well as for evaluation of treatment effectiveness during follow-up. Learn more:
Twice per year, EuroFlow organizes an external Quality Assessment program. Labs around the world can join this program to evaluate their whole flow cytometric analysis process and obtain a certificate upon good performance. Registration for the autumn round is open untill August 31st.
EuroFlow has developed several Standard Operating Procedures to contribute to the standardization of your daily lab-routines. Recently, the EuroFlow team has updated several of those SOPs. You can find them in our 'Login Area'. An account is made in only a few seconds.
News
Events
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
Upcoming events
ESLHO, together with the independent scientific foundations EuroFlow, EuroClonality and EuroMRD, is an official EHA Specialized Working Group (SWG).
